Kiniksa Pharmaceuticals International, plc KNSA Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on trailing twelve months.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's return on invested capital?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported return on invested capital of 17.5% in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's return on invested capital changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's return on invested capital increased by 439.3% year-over-year, from -5.2% to 17.5%.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's return on invested capital?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's return on invested capital has grown at a -28.6% compound annual growth rate (CAGR), from -81.5% to 15.2%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.